InsidersTradesSigma
Explore the full record of transactions filed by Carruthers R Michael, Chief Financial Officer. Officer active across 1 companies, notably Edgewise Therapeutics, Inc.. Cumulatively, 1 reports have been published. The latest transaction was filed on 23 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
R. Michael Carruthers is the Chief Financial Officer at Edgewise Therapeutics, Inc. He is responsible for managing the company's finances, including financial planning, risk management, and financial compliance. Carruthers plays a crucial role in financial strategy and the sustainability of the organization.